Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail
-

Public Calendar for Week of Oct. 1-5, 2007

 

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

FDA Official and Title Date Location Other FDA Participants Non-FDA Participants Subject
Andrew von Eschenbach, Commissioner, Food and Drugs 10/2/07 Rockville, MD Randy Lutter, Larry Bachorik, Laurie Lenkel, Julie Zawisa, Les Weinstein, Virginia Behr, Howard Balick, Beth Clarke Joe Panetta, Ben Avery, Michele Yelemene, Michael Mentesana (BIOCom) BIOCom’s 2006 survey of pharmaceutical, biotechnology, and medical device companies and their working relationship with FDA
Andrew von Eschenbach, Commissioner, Food and Drugs 10/4/07 Rockville, MD Patricia Keegan, Seth Ray, Jeffrey Senger, Richard Pazdur, Susan Winckler, Patricia Delaney, Yolanda Jenkins   Baker Donelson Bearnan, Nancy Johnson, Lance Leggitt (Caldwell & Berkowitz, PC), Ted Okon (Community Oncology Alliance (COA), Lee  Schwartzberg (The West Clinic), Arthur Staddon (University of Pennsylvania Health System) FDA panel recommendations related to anemia drugs
John Dyer, Deputy Commissioner for Operations and Chief Operating Officer 10/1/07 through 10/5/07 N/A N/A N/A No significant meetings
Murray Lumpkin, Deputy Commissioner for International and Special Programs 10/1/07 through 10/5/07 N/A N/A N/A No significant meetings
Randall Lutter, Deputy Commissioner for Policy 10/4/07 Teleconference N/A Michael Lazarus, Bob Wolfe, Ron Keurbitz (Fresenius Medical Care North America) Renal Data Analyses
Randall Lutter, Deputy Commissioner for Policy 10/4/07 Rockville, MD Irene Chan Ian Ascough, William Sargent (Dept. for Business, Enterprise and Regulatory Reform) Regulatory reform issues for the UK government
Janet Woodcock, Deputy Commissioner for Scientific and Medical Programs,  Chief Medical Officer and Acting Director, Center for Drug Evaluation and Research 10/1/07 Cleveland, OH N/A Ellen Sigal, Marlene Malek (Friends of Cancer Research), John Niederhuber (NIH) Critical Path Initiative as it relates to cancer research
Janet Woodcock, Deputy Commissioner for Scientific and Medical Programs,  Chief Medical Officer and Acting Director, Center for Drug Evaluation and Research 10/5/07 Washington, DC Robert Temple, Robert O'Neill, Ann Staten Ellen Stoval (National Coalition for Cancer Survivorship) Workshop on improving cancer clinical trials
Margaret Glavin, Associate Commissioner, Office of Regulatory Affairs 10/1/07 through 10/5/07 N/A N/A N/A No significant meetings
Jesse Goodman, Director, Center for Biologics Evaluation and Research 10/5/07 Geneva, Switzerland N/A WHO Pandemic influenza vaccines
Daniel Schultz, Director, Center for Devices and Radiological Health 10/2/07 Rockville, MD Tom Gross, David Buckles, Lily Ng Susan Alpert, Scott Ward (Metronic) Device issues
Daniel Schultz, Director, Center for Devices and Radiological Health 10/3-4/07 Washington, DC Committee members Conference Global Harmonization Task Force Conference
Daniel Schultz, Director, Center for Devices and Radiological Health 10/5/07 Rockville, MD N/A Robert Jarvik (Jarvik Heart) Device issues
Robert Brackett, Director, Center for Food Safety and Applied Nutrition 10/1/07 through 10/5/07 N/A N/A N/A No significant meetings
Stephen Sundlof, Director, Center for Veterinary Medicine 10/3/07 Teleconference Merton Smith, Steve Vaughn, Dan McChesney Ian Alexander, Louis Boulay, Manisha Mehrotra, Michelle Nicholson, Rajinder Sharma (Canadian Veterinary Drugs Directorate Staff) Bilateral meeting with the Canadian Veterinary Drugs Directorate to discuss mutual veterinary drug issues
William Slikker, Director, National Center for Toxicological Research (NCTR) 10/1/07 through 10/5/07 N/A N/A N/A No significant meetings
Jeffrey Senger, Acting Chief Counsel 10/1/07 through 10/5/07 N/A N/A N/A No significant meetings

 

-
-